| You
are here: Home: BCU 2|2003: Michael
Baum, ChM, FRCS: Select publications
Select publications
Mammographic screening in women under 50 years old
16-year mortality from breast cancer in the UK Trial of
Early Detection of Breast Cancer. Lancet 1999;353(9168):1909-14.
Abstract
Alexander FE et al. 14 years of follow-up from the Edinburgh
randomised trial of breast-cancer screening. Lancet 1999;353(9168):1903-8.
Abstract
Andersson I, Janzon L. Reduced breast cancer mortality
in women under age 50: Updated results from the Malmo Mammographic
Screening Program. J Natl Cancer Inst Monogr 1997;(22):63-7.
Abstract
Bjurstam N et al. The Gothenburg Breast Cancer Screening
Trial: Preliminary results on breast cancer mortality for women
aged 39-49. J Natl Cancer Inst Monogr 1997;(22):53-5. Abstract
Cox B. Variation in the effectiveness of breast screening
by year of follow-up. J Natl Cancer Inst Monogr 1997;(22):69-72.
Abstract
Frisell J, Lidbrink E. The Stockholm Mammographic Screening
Trial: Risks and benefits in age group 40-49 years. J Natl
Cancer Inst Monogr 1997;(22):49-51. Abstract
Kerlikowske K. Efficacy of screening mammography among
women aged 40 to 49 years and 50 to 69 years: Comparison of relative
and absolute benefit. J Natl Cancer Inst Monogr 1997;(22):79-86.
Abstract
Larsson LG et al. Updated overview of the Swedish Randomized
Trials on Breast Cancer Screening with Mammography: Age group 40-49
at randomization. J Natl Cancer Inst Monogr 1997;(22):57-61.
Abstract
Miller AB et al. The Canadian National Breast Screening
Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up.
A randomized screening trial of Mammography in women age 40 to 49
years. Annals of Internal Medicine 2002;137(5):305-315.
Abstract
Morimoto T et al. Breast cancer screening by mammography
in women aged under 50 years in Japan. Anticancer Res 2000;20(5C):3689-94.
Abstract.
Peer PG et al. Effect on breast cancer mortality of biennial
mammographic screening of women under age 50. Int J Cancer
1995;60(6):808-11. Abstract
Retsky M et al. Premenopausal status accelerates relapse
in node positive breast cancer: Hypothesis links angiogenesis, screening
controversy. Breast Cancer Res Treat 2001;65(3):217-24.
Abstract
|
